Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro

References

• Pastorekova S Zatovicova M Pastorek J Cancer-associated carbonic anhydrases and their inhibition Curr Pharm Des 2008 14 7 685 698 18336315
   PubMed Web of Science ®Google Scholar
• Liao SY Aurelio ON Jan K Zavada J Stanbridge EJ Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney Cancer Res 1997 57 14 2827 2831 9230182
   PubMed Web of Science ®Google Scholar
• Saarnio J Parkkila S Parkkila AK Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation Am J Pathol 1998 153 1 279 285 9665489
   PubMed Web of Science ®Google Scholar
• Wykoff CC Beasley N Watson PH Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast Am J Pathol 2001 158 3 1011 1019 11238049
   PubMed Web of Science ®Google Scholar
• Vermylen P Roufosse C Burny A Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma Eur Respir J 1999 14 4 806 811 10573225
   PubMed Web of Science ®Google Scholar
• Loncaster JA Harris AL Davidson SE Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix Cancer Res 2001 61 17 6394 6399 11522632
   PubMed Web of Science ®Google Scholar
• Ilie M Mazure NM Hofman V High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer Br J Cancer 2010 102 11 1627 1635 20461082
   PubMed Web of Science ®Google Scholar
• Chia SK Wykoff CC Watson PH Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma J Clin Oncol 2001 19 16 3660 3668 11504747
   PubMed Web of Science ®Google Scholar
• Måseide K Kandel RA Bell RS Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma Clin Cancer Res 2004 10 13 4464 4471 15240538
   PubMed Web of Science ®Google Scholar
• Haapasalo JA Nordfors KM Hilvo M Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis Clin Cancer Res 2006 12 2 473 477 16428489
   PubMed Web of Science ®Google Scholar
• Le QT Chen E Salim A An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers Clin Cancer Res 2006 12 5 1507 1514 16533775
   PubMed Web of Science ®Google Scholar
• Swinson DE Jones JL Richardson D Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer J Clin Oncol 2003 21 3 473 482 12560438
   PubMed Web of Science ®Google Scholar
• Pastoreková S Parkkila S Parkkila AK Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts Gastroenterology 1997 112 2 398 408 9024293
   PubMed Web of Science ®Google Scholar
• Kivelä AJ Parkkila S Saarnio J Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours Histochem Cell Biol 2000 114 3 197 204 11083462
   PubMed Web of Science ®Google Scholar
• Karhumaa P Kaunisto K Parkkila S Expression of the transmembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts Mol Hum Reprod 2001 7 7 611 616 11420383
   PubMed Web of Science ®Google Scholar
• Surfus JE Hank JA Oosterwijk E Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors J Immunother Emphasis Tumor Immunol 1996 19 3 184 191 8811493
   PubMed Web of Science ®Google Scholar
• Siebels M Rohrmann K Oberneder R A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients World J Urol 2011 29 1 121 126 20512580
   PubMed Web of Science ®Google Scholar
• Zatovicova M Jelenska L Hulikova A Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain Curr Pharm Des 2010 16 29 3255 3263 20819068
   PubMed Web of Science ®Google Scholar
• Torchilin VP Recent advances with liposomes as pharmaceutical carriers Nat Rev Drug Discov 2005 4 2 145 160 15688077
   PubMed Web of Science ®Google Scholar
• Kontermann RE Immunoliposomes for cancer therapy Curr Opin Mol Ther 2006 8 1 39 45 16506524
   PubMedGoogle Scholar
• Shinkai M Le B Honda H Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes Jpn J Cancer Res 2001 92 10 1138 1145 11676866
   PubMedGoogle Scholar
• Wykoff CC Beasley NJ Watson PH Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res 2000 60 24 7075 7083 11156414
   PubMed Web of Science ®Google Scholar
• Pons M Foradada M Estelrich J Liposomes obtained by the ethanol injection method Int J Pharm 1993 95 1–3 51 56
   Web of Science ®Google Scholar
• Iden DL Allen TM In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach Biochim Biophys Acta 2001 1513 2 207 216 11470092
   PubMed Web of Science ®Google Scholar
• Manjappa AS Chaudhari KR Venkataraju MP Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor J Control Release 2011 150 1 2 22 21095210
   PubMed Web of Science ®Google Scholar
• Závada J Závadová Z Zat’ovicová M Hyrsl L Kawaciuk I Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients Br J Cancer 2003 89 6 1067 1071 12966427
   PubMed Web of Science ®Google Scholar
• Medina OP Zhu Y Kairemo K Targeted liposomal drug delivery in cancer Curr Pharm Des 2004 10 24 2981 2989 15379663
   PubMed Web of Science ®Google Scholar
• Iyer AK Khaled G Fang J Maeda H Exploiting the enhanced permeability and retention effect for tumor targeting Drug Discov Today 2006 11 17–18 812 818 16935749
   PubMed Web of Science ®Google Scholar
• Danhier F Feron O Préat V To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J Control Release 2010 148 2 135 146 20797419
   PubMed Web of Science ®Google Scholar
• Choi HS Liu W Misra P Renal clearance of quantum dots Nat Biotechnol 2007 25 10 1165 1170 17891134
   PubMed Web of Science ®Google Scholar
• Immordino ML Dosio F Cattel L Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int J Nanomedicine 2006 1 3 297 315 17717971
   PubMed Web of Science ®Google Scholar
• Sheehan JP Sheehan JM Holmberg EG Geisert EE Helm GA A horseradish peroxidase-light and electron microscopic study of immunoliposomes utilized for intracellular delivery to the rat striatum Neurosci Lett 2002 333 3 212 216 12429385
   PubMed Web of Science ®Google Scholar
• Mellor HR Callaghan R Accumulation and distribution of doxorubicin in tumour spheroids: the influence of acidity and expression of P-glycoprotein Cancer Chemother Pharmacol 2011 68 5 1179 1190 21400240
   PubMed Web of Science ®Google Scholar
• Thews O Nowak M Sauvant C Gekle M Hypoxia-induced extracellular acidosis increases p-glycoprotein activity and chemoresistance in tumors in vivo via p38 signaling pathway Adv Exp Med Biol 2011 701 115 122 21445777
   PubMed Web of Science ®Google Scholar
• Xiao-Dong L Zhi-Hong Y Hui-Wen Y Repetitive/temporal hypoxia increased P-glycoprotein expression in cultured rat brain microvascular endothelial cells in vitro Neurosci Lett 2008 432 3 184 187 18241990
   PubMed Web of Science ®Google Scholar
• Xia S Yu S Yuan X Effects of hypoxia on expression of P-gp and mutltidrug resistance protein in human lung adenocarcinoma A549 cell line J Huazhong Univ Sci Technolog Med Sci 2005 25 3 279 281 16201271
   PubMedGoogle Scholar
• Omelyanenko V Kopecková P Gentry C Kopecek J Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate J Control Release 1998 53 1–3 25 37 9741911
   PubMed Web of Science ®Google Scholar
• Shen F Chu S Bence AK Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells J Pharmacol Exp Ther 2008 324 1 95 102 17947497
   PubMed Web of Science ®Google Scholar
• Baas P Belderbos JS van den Heuvel M Chemoradiation therapy in nonsmall cell lung cancer Curr Opin Oncol 2011 23 2 140 149 21178617
   PubMed Web of Science ®Google Scholar
• Onn A Isobe T Itasaka S Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice Clin Cancer Res 2003 9 15 5532 5539 14654533
   PubMed Web of Science ®Google Scholar
• Gagnadoux F Pape AL Lemarié E Aerosol delivery of chemotherapy in an orthotopic model of lung cancer Eur Respir J 2005 26 4 657 661 16204597
   PubMed Web of Science ®Google Scholar
• Mercadal M Domingo JC Petriz J Garcia J de Madariaga MA Preparation of immunoliposomes bearing poly(ethylene glycol)-coupled monoclonal antibody linked via a cleavable disulfide bond for ex vivo applications Biochim Biophys Acta 2000 1509 1–2 299 310 11118541
   PubMed Web of Science ®Google Scholar
• Mercadal M Domingo JC Petriz J Garcia J de Madariaga MA A novel strategy affords high-yield coupling of antibody to extremities of liposomal surface-grafted PEG chains Biochim Biophys Acta 1999 1418 1 232 238 10209227
   PubMed Web of Science ®Google Scholar